TWI857027B - 心肌肌鈣蛋白活化劑之多晶型物 - Google Patents
心肌肌鈣蛋白活化劑之多晶型物 Download PDFInfo
- Publication number
- TWI857027B TWI857027B TW109108225A TW109108225A TWI857027B TW I857027 B TWI857027 B TW I857027B TW 109108225 A TW109108225 A TW 109108225A TW 109108225 A TW109108225 A TW 109108225A TW I857027 B TWI857027 B TW I857027B
- Authority
- TW
- Taiwan
- Prior art keywords
- peaks
- xrpd
- radiation
- compound
- further characterized
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962817194P | 2019-03-12 | 2019-03-12 | |
| US62/817,194 | 2019-03-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202100517A TW202100517A (zh) | 2021-01-01 |
| TWI857027B true TWI857027B (zh) | 2024-10-01 |
Family
ID=70190163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109108225A TWI857027B (zh) | 2019-03-12 | 2020-03-12 | 心肌肌鈣蛋白活化劑之多晶型物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220185791A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3938042A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022525102A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114025845A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI857027B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020185983A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020004800A2 (pt) | 2017-09-13 | 2020-09-24 | Amgen Inc. | compostos de bisamida ativantes do sarcômero e seus usos |
| SG11202109891WA (en) | 2019-03-12 | 2021-10-28 | Amgen Inc | Polymorphs and cocrystals of a cardiac troponin activator |
| EP4308095A4 (en) | 2021-03-15 | 2025-02-19 | Maze Therapeutics, Inc. | GLYCOGEN SYNTHASE 1 (GYS1) INHIBITORS AND METHODS OF USE THEREOF |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| AU3192500A (en) * | 1999-03-16 | 2000-10-04 | C & C Research Laboratories | Substituted proline derivatives and medicinal compositions containing the same |
| TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
| EP3821882A1 (en) * | 2013-03-14 | 2021-05-19 | Amgen Inc. | Heterocyclic compounds and their uses |
| BR112020004800A2 (pt) * | 2017-09-13 | 2020-09-24 | Amgen Inc. | compostos de bisamida ativantes do sarcômero e seus usos |
-
2020
- 2020-03-12 US US17/593,113 patent/US20220185791A1/en not_active Abandoned
- 2020-03-12 TW TW109108225A patent/TWI857027B/zh not_active IP Right Cessation
- 2020-03-12 EP EP20717440.0A patent/EP3938042A1/en not_active Withdrawn
- 2020-03-12 WO PCT/US2020/022221 patent/WO2020185983A1/en not_active Ceased
- 2020-03-12 CN CN202080034295.8A patent/CN114025845A/zh active Pending
- 2020-03-12 JP JP2021554692A patent/JP2022525102A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020185983A1 (en) | 2020-09-17 |
| CN114025845A (zh) | 2022-02-08 |
| EP3938042A1 (en) | 2022-01-19 |
| JP2022525102A (ja) | 2022-05-11 |
| US20220185791A1 (en) | 2022-06-16 |
| TW202100517A (zh) | 2021-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12612366B2 (en) | Salts and crystal forms of omecamtiv mecarbil | |
| EP3443960A1 (en) | Crystalline form of trisodium supramolecular complex comprising valsartan and ahu-377 and methods thereof | |
| US20250367186A1 (en) | C-Met Modulator Pharmaceutical Compositions | |
| CN114008024A (zh) | 具有铁死亡诱导活性的化合物以及使用其的方法 | |
| CN117417263A (zh) | Rad1901-2hcl的多晶型形式 | |
| EP3233809A1 (en) | Formulations of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methycyclohexylamino)-pyrimidine-5-carboxamide | |
| TW202100517A (zh) | 心肌肌鈣蛋白活化劑之多晶型物 | |
| TWI838482B (zh) | 心肌肌鈣蛋白活化劑之多晶型物及共晶 | |
| EA028059B1 (ru) | Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида | |
| CN114349745B (zh) | 一种用于治疗心肌缺血的药物及其制备方法 | |
| CN120676939A (zh) | Pi3k抑制剂及其制备和使用方法 | |
| EA044681B1 (ru) | Полиморфы и сокристаллы активатора кардиотропонина | |
| CN101972240B (zh) | 莫达芬尼组合物 | |
| WO2024164066A1 (en) | Crystalline forms of acalabrutinib maleate | |
| HK40068824A (en) | Polymorphs and cocrystals of a cardiac troponin activator | |
| WO2000027807A1 (en) | Polymorphic forms of an amyloidosis inhibitor and methods of preparation | |
| WO2025224069A1 (en) | Co-crystals of finerenone, pecavaptan, and sglt2 inhibitors | |
| US20160194281A1 (en) | Crystalline forms of silodosin | |
| HK40067758A (en) | Compounds with ferroptosis inducing activity and methods of their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |